|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
HU196714B
(en)
|
1984-10-04 |
1989-01-30 |
Monsanto Co |
Process for producing non-aqueous composition comprising somatotropin
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
PH30995A
(en)
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
ATE205542T1
(de)
|
1992-03-04 |
2001-09-15 |
Univ California |
Vergleichende genomhybridisierung
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US6087324A
(en)
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US5863949A
(en)
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
|
DK0821671T3
(da)
|
1995-04-20 |
2001-04-23 |
Pfizer |
Arylsulfonylhydroxamsyrederivater som MMP- og TNF-inhibitorer
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
AU6242096A
(en)
|
1995-06-27 |
1997-01-30 |
Takeda Chemical Industries Ltd. |
Method of producing sustained-release preparation
|
|
TW448055B
(en)
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
|
JP2909418B2
(ja)
|
1995-09-18 |
1999-06-23 |
株式会社資生堂 |
薬物の遅延放出型マイクロスフイア
|
|
DE69624081T2
(de)
|
1995-12-20 |
2003-06-12 |
Agouron Pharmaceuticals, Inc. |
Matrix-metalloprotease Inhibitoren
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
US6264970B1
(en)
|
1996-06-26 |
2001-07-24 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
JP3195756B2
(ja)
|
1996-07-04 |
2001-08-06 |
公子 吉水 |
潤滑補助体
|
|
EP0923585B1
(en)
|
1996-07-18 |
2002-05-08 |
Pfizer Inc. |
Phosphinate based inhibitors of matrix metalloproteases
|
|
WO1998007697A1
(en)
|
1996-08-23 |
1998-02-26 |
Pfizer Inc. |
Arylsulfonylamino hydroxamic acid derivatives
|
|
US6419961B1
(en)
|
1996-08-29 |
2002-07-16 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsules of a bioactive substance and a biodegradable polymer
|
|
CA2217134A1
(en)
|
1996-10-09 |
1998-04-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Sustained release formulation
|
|
DE69730093T2
(de)
|
1996-10-31 |
2006-07-20 |
Takeda Pharmaceutical Co. Ltd. |
Zubereitung mit verzögerter Freisetzung
|
|
WO1998027980A2
(en)
|
1996-12-20 |
1998-07-02 |
Takeda Chemical Industries, Ltd. |
Method of producing a sustained-release preparation
|
|
WO1998030566A1
(en)
|
1997-01-06 |
1998-07-16 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
|
EP0977733B1
(en)
|
1997-02-03 |
2003-09-03 |
Pfizer Products Inc. |
Arylsulfonylamino hydroxamic acid derivatives
|
|
JP2000507975A
(ja)
|
1997-02-07 |
2000-06-27 |
ファイザー・インク |
Ｎ−ヒドロキシ−β−スルホニルプロピオンアミド誘導体類及びそれらのマトリックスメタロプロテイナーゼ阻害薬としての使用
|
|
EA002546B1
(ru)
|
1997-02-11 |
2002-06-27 |
Пфайзер Инк. |
Производные арилсульфонилгидроксамовой кислоты
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
|
US6613358B2
(en)
|
1998-03-18 |
2003-09-02 |
Theodore W. Randolph |
Sustained-release composition including amorphous polymer
|
|
US6432970B2
(en)
|
1998-04-09 |
2002-08-13 |
Johns Hopkins University School Of Medicine |
Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
|
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
|
KR19990085365A
(ko)
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
|
US6927024B2
(en)
|
1998-11-30 |
2005-08-09 |
Genentech, Inc. |
PCR assay
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US20070021493A1
(en)
|
1999-09-16 |
2007-01-25 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
AU780846B2
(en)
|
1999-09-16 |
2005-04-21 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
CA2386190C
(en)
|
1999-10-13 |
2009-04-14 |
Johns Hopkins University School Of Medicine |
Regulators of the hedgehog pathway, compositions and uses related thereto
|
|
CA2388468C
(en)
|
1999-10-14 |
2011-01-25 |
Curis, Inc. |
Mediators of hedgehog signalling pathways, compositions and uses related thereto
|
|
WO2001042507A1
(en)
|
1999-12-09 |
2001-06-14 |
Advanced Research & Technology Institute |
Fluorescent in situ rt-pcr
|
|
IL133809A0
(en)
|
1999-12-30 |
2001-04-30 |
Yeda Res & Dev |
Steroidal alkaloids and pharmaceutical compositions comprising them
|
|
CA2404413C
(en)
|
2000-03-30 |
2015-10-20 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
CN100523216C
(zh)
|
2001-03-02 |
2009-08-05 |
匹兹堡大学 |
Pcr方法
|
|
JP4658473B2
(ja)
|
2001-07-27 |
2011-03-23 |
キュリス，インコーポレイテッド |
ヘッジホッグシグナル伝達経路メディエーター、それに関連した組成物及び利用
|
|
ES2367422T3
(es)
|
2001-10-09 |
2011-11-03 |
Amgen Inc. |
Derivados de imidazol como agentes antiinflamatorios.
|
|
US20030113828A1
(en)
|
2001-11-09 |
2003-06-19 |
Ginsberg Mark H. |
Compositions and methods for modulating Syk function
|
|
US20030158195A1
(en)
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
|
DE60322869D1
(de)
|
2002-04-22 |
2008-09-25 |
Univ Johns Hopkins |
Modulatoren von hedgehog signalpfaden, zusammensetzungen und verwandte verwendungen
|
|
AU2003265853A1
(en)
|
2002-08-29 |
2004-03-19 |
Curis, Inc. |
Hedgehog antagonists, methods and uses related thereto
|
|
JP2006512313A
(ja)
|
2002-10-31 |
2006-04-13 |
アムジェン インコーポレイテッド |
抗炎症剤
|
|
FR2850022B1
(fr)
|
2003-01-22 |
2006-09-08 |
Centre Nat Rech Scient |
Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications
|
|
US7173015B2
(en)
|
2003-07-03 |
2007-02-06 |
The Trustees Of The University Of Pennsylvania |
Inhibition of Syk kinase expression
|
|
WO2005013800A2
(en)
|
2003-07-15 |
2005-02-17 |
The Johns Hopkins University |
Elevated hedgehog pathway activity in digestive system tumors, and methods of treating digestive system tumors having elevated hedgehog pathway activity
|
|
WO2005016348A1
(en)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
|
US8067608B2
(en)
|
2003-09-29 |
2011-11-29 |
The Johns Hopkins University |
Hedgehog pathway antagonists
|
|
WO2005032343A2
(en)
|
2003-10-01 |
2005-04-14 |
The Johns Hopkins University |
Hedgehog signaling in prostate regeneration neoplasia and metastasis
|
|
US20080057071A1
(en)
|
2003-10-20 |
2008-03-06 |
Watkins David N |
Use Of Hedgehog Pathway Inhibitors In Small-Cell Lung Cancer
|
|
WO2005049838A2
(en)
|
2003-11-14 |
2005-06-02 |
Yale University |
Syk-targeted nucleic acid interference
|
|
US7122799B2
(en)
|
2003-12-18 |
2006-10-17 |
Palo Alto Research Center Incorporated |
LED or laser enabled real-time PCR system and spectrophotometer
|
|
US8057815B2
(en)
|
2004-04-19 |
2011-11-15 |
Portola Pharmaceuticals, Inc. |
Methods of treatment with Syk inhibitors
|
|
US8273743B2
(en)
|
2004-04-30 |
2012-09-25 |
Curis, Inc. |
Quinoxaline inhibitors of the hedgehog signalling
|
|
SI2612862T1
(sl)
|
2004-05-13 |
2017-04-26 |
Icos Corporation |
Kinazolini kot inhibitorji humane fosfatidilinozitol 3-kinaze delta
|
|
EP2316832B1
(en)
|
2004-08-27 |
2017-03-08 |
Infinity Pharmaceuticals, Inc. |
Cyclopamine analogues and methods of use thereof
|
|
DK1789390T3
(da)
|
2004-09-02 |
2012-02-27 |
Genentech Inc |
Pyridyl-inhibitorer af hedgehog-signalering
|
|
CN101083996A
(zh)
|
2004-10-28 |
2007-12-05 |
Irm责任有限公司 |
作为hedgehog途径调节剂的化合物和组合物
|
|
WO2006093247A1
(ja)
|
2005-02-28 |
2006-09-08 |
Japan Tobacco Inc. |
Ｓｙｋ阻害活性を有する新規なアミノピリジン化合物
|
|
EP1945202A2
(en)
|
2005-11-11 |
2008-07-23 |
Licentia OY |
Mammalian hedgehog signaling inhiabitors
|
|
US8101610B2
(en)
|
2005-11-14 |
2012-01-24 |
Genentech, Inc. |
Bisamide inhibitors of hedgehog signaling
|
|
JP2009530342A
(ja)
|
2006-03-20 |
2009-08-27 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｂｔｋおよびｓｙｋ蛋白キナーゼを阻害する方法
|
|
EP2010170A2
(en)
|
2006-04-14 |
2009-01-07 |
Novartis AG |
Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders
|
|
UA93548C2
(uk)
|
2006-05-05 |
2011-02-25 |
Айерем Елелсі |
Сполуки та композиції як модулятори хеджхогівського сигнального шляху
|
|
EP2026775B1
(en)
|
2006-05-09 |
2015-04-29 |
Novaremed Ltd. |
Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders
|
|
CA2663091A1
(en)
|
2006-09-07 |
2008-03-13 |
Biogen Idec Ma Inc. |
Modulators of interleukin-1 receptor-associated kinase
|
|
CN103435694A
(zh)
|
2006-10-31 |
2013-12-11 |
美国政府卫生与公共服务部 |
Smoothened多肽及使用方法
|
|
AU2007332493A1
(en)
|
2006-12-14 |
2008-06-19 |
Daiichi Sankyo Company, Limited |
Imidazothiazole derivatives
|
|
TWI433674B
(zh)
|
2006-12-28 |
2014-04-11 |
Infinity Discovery Inc |
環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
|
|
WO2008109184A1
(en)
|
2007-03-07 |
2008-09-12 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic cyclopamine analogs and methods of use thereof
|
|
NZ579356A
(en)
|
2007-03-07 |
2012-04-27 |
Infinity Pharmaceuticals Inc |
Cyclopamine lactam analogs and methods of use thereof
|
|
CN101679308B
(zh)
|
2007-03-14 |
2014-05-07 |
埃克塞里艾克西斯公司 |
Hedgehog途径抑制剂
|
|
PE20090188A1
(es)
|
2007-03-15 |
2009-03-20 |
Novartis Ag |
Compuestos heterociclicos como moduladores de la senda de hedgehog
|
|
WO2008131354A2
(en)
|
2007-04-20 |
2008-10-30 |
The Curators Of The University Of Missouri |
Phytoestrogens as regulators of hedgehog signaling and methods of their use in cancer treatment
|
|
US20090012031A1
(en)
|
2007-07-03 |
2009-01-08 |
The Regents Of The University Of Michigan |
EZH2 Cancer Markers
|
|
CA2709203A1
(en)
|
2007-12-13 |
2009-06-18 |
Siena Biotech S.P.A. |
Hedgehog pathway antagonists and therapeutic applications thereof
|
|
EP3613743B1
(en)
|
2008-01-04 |
2022-03-16 |
Intellikine, LLC |
Processes for the preparation of 1h-pyrazolo[3,4-d]pyrimidin-4-amine derivatives
|
|
US8193182B2
(en)
*
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
EP2228350A4
(en)
|
2008-01-10 |
2010-12-29 |
Asahi Glass Co Ltd |
GLASS, COATING MATERIAL FOR A LIGHT EMITTING DEVICE AND LIGHT EMITTING DEVICE
|
|
WO2009089598A2
(en)
|
2008-01-18 |
2009-07-23 |
Katholieke Universiteit Leuven |
Msmb-gene methylation based diagnosis, staging and prognosis of prostate cancer
|
|
US8637542B2
(en)
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
|
FR2929851B1
(fr)
|
2008-04-09 |
2012-11-30 |
Centre Nat Rech Scient |
Molecules inhibant une voie metabolique impliquant la proteine tyrosine kinase syk et procede d'identification de ces molecules
|
|
MX2010011463A
(es)
|
2008-04-16 |
2011-06-03 |
Portola Pharm Inc |
2,6-diamino-pirimidin-5-il-carboxamidas como inhibidores de syk o jak quinasas.
|
|
JP5788316B2
(ja)
|
2008-07-08 |
2015-09-30 |
インテリカイン， エルエルシー |
キナーゼインヒビターおよび使用方法
|
|
US8703778B2
(en)
|
2008-09-26 |
2014-04-22 |
Intellikine Llc |
Heterocyclic kinase inhibitors
|
|
US9107942B2
(en)
|
2008-10-31 |
2015-08-18 |
University Of Rochester |
Methods of diagnosing and treating fibrosis
|
|
CN102271683B
(zh)
*
|
2008-11-13 |
2014-07-09 |
吉里德卡利斯托加公司 |
恶性血液病的治疗
|
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
|
EA021293B1
(ru)
|
2008-12-08 |
2015-05-29 |
Джилид Коннектикут, Инк. |
ИМИДАЗОПИРАЗИНОВЫЕ ИНГИБИТОРЫ Syk, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ИМИДАЗОПИРАЗИНОВЫЕ ИНГИБИТОРЫ Syk, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
|
AU2010219097A1
(en)
|
2009-01-13 |
2011-08-04 |
Glaxo Group Limited |
Pyrimidinecarboxamide derivatives as inhibitors of SYK kinase
|
|
US8642602B2
(en)
|
2009-02-04 |
2014-02-04 |
University Of Georgia Research Foundation, Inc. |
Method of inhibiting fibrogenesis and treating fibrotic disease
|
|
CN102459272B
(zh)
|
2009-05-27 |
2014-08-06 |
健泰科生物技术公司 |
对P110δ具有选择性的为PI3K抑制剂的二环嘧啶化合物和使用方法
|
|
CA2772371A1
(en)
|
2009-05-27 |
2010-12-02 |
F. Hoffmann-La Roche Ag |
Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
WO2010147898A2
(en)
|
2009-06-15 |
2010-12-23 |
Rigel Pharmaceuticals, Inc. |
Small molecule inhibitors of spleen tyrosine kinase (syk)
|
|
TW201105669A
(en)
|
2009-07-30 |
2011-02-16 |
Irm Llc |
Compounds and compositions as Syk kinase inhibitors
|
|
JP2013501002A
(ja)
|
2009-07-30 |
2013-01-10 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Ｓｙｋキナーゼ阻害剤としての化合物および組成物
|
|
KR20120081164A
(ko)
|
2009-09-29 |
2012-07-18 |
엑스커버리 홀딩 컴퍼니 엘엘씨 |
Ｐｉ3ｋ(델타) 선택적 억제제
|
|
WO2011075517A1
(en)
|
2009-12-17 |
2011-06-23 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
US8735417B2
(en)
|
2009-12-17 |
2014-05-27 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as Syk inhibitors
|
|
SG181857A1
(en)
|
2009-12-23 |
2012-07-30 |
Takeda Pharmaceutical |
Fused heteroaromatic pyrrolidinones as syk inhibitors
|
|
WO2011103016A2
(en)
|
2010-02-19 |
2011-08-25 |
The Regents Of The University Of Michigan |
Compositions and methods for inhibiting ezh2
|
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
|
CA2799579A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
CN107898791A
(zh)
*
|
2010-06-03 |
2018-04-13 |
药品循环有限责任公司 |
布鲁顿酪氨酸激酶(btk)抑制剂的应用
|
|
US20110306622A1
(en)
*
|
2010-06-11 |
2011-12-15 |
Calitoga Pharmaceuticals, Inc. |
Methods of treating hematological disorders with quinazolinone compounds in selected subjects
|
|
US20130195843A1
(en)
|
2010-06-23 |
2013-08-01 |
British Columbia Cancer Agency Branch |
Biomarkers for Non-Hodgkin Lymphomas and Uses Thereof
|
|
US9175331B2
(en)
|
2010-09-10 |
2015-11-03 |
Epizyme, Inc. |
Inhibitors of human EZH2, and methods of use thereof
|
|
BR112013005806B1
(pt)
|
2010-09-10 |
2022-05-10 |
Epizyme, Inc |
Métodos para detectar se um indivíduo é um candidato para o tratamento com ou responsivo a um inibidor de ezh2 e usos terapêuticos do dito inibidor de ezh2
|
|
EP2635556B1
(en)
|
2010-11-01 |
2017-06-21 |
Portola Pharmaceuticals, Inc. |
Benzamides and nicotinamides as syk modulators
|
|
TWI674262B
(zh)
*
|
2011-01-10 |
2019-10-11 |
美商英菲尼提製藥股份有限公司 |
製備異喹啉酮之方法及異喹啉酮之固體形式
|
|
US20130004481A1
(en)
*
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
|
BR112013028430A2
(pt)
|
2011-05-04 |
2017-08-01 |
Merck Sharp & Dohme |
composto, composição farmacêutica, método para tratar uma doença ou condição mediada por tirosina quinase do baço (syk), e, uso de uma quantidade terapeuticamente eficiente do composto
|
|
MX2014000648A
(es)
|
2011-07-19 |
2014-09-25 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos.
|
|
BR112014001255B1
(pt)
|
2011-07-19 |
2019-07-02 |
Merck Sharp & Dohme B.V. |
Composto, uso de um composto, combinação, composição farmacêutica, e, sal farmaceuticamente aceitável de um composto
|
|
WO2013012915A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
KR20140075693A
(ko)
|
2011-08-29 |
2014-06-19 |
인피니티 파마슈티칼스, 인코포레이티드 |
헤테로사이클릭 화합물 및 그의 용도
|
|
WO2013059738A2
(en)
*
|
2011-10-19 |
2013-04-25 |
Pharmacyclics, Inc. |
Use of inhibitors of bruton's tyrosine kinase (btk)
|
|
CN109970742A
(zh)
|
2012-07-04 |
2019-07-05 |
理森制药股份公司 |
选择性PI3Kδ抑制剂
|
|
CN104704129A
(zh)
*
|
2012-07-24 |
2015-06-10 |
药品循环公司 |
与对布鲁顿酪氨酸激酶(btk)抑制剂的抗性相关的突变
|
|
EP2914296B2
(en)
*
|
2012-11-01 |
2021-09-29 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
WO2015160975A2
(en)
*
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
RU2754507C2
(ru)
*
|
2016-06-24 |
2021-09-02 |
Инфинити Фармасьютикалз, Инк. |
Комбинированная терапия
|